Originally published May 3, 2021
The first-of-its-kind HER2CLIMB breast cancer study was a career-defining achievement for Dr. Nancy U. Lin.
In 2020, she was invited to present her work at the ASCO Annual Meeting; in 2021, the study was among the lauded list of research covered in Clinical Cancer Advances 2021: ASCO’s Report on Progress Against Cancer.
As she works to prevent breast cancer and uncover more treatment options, the two-time recipient of grants from Conquer Cancer, the ASCO Foundation, is motivated by the patients who have contributed to her discoveries and the colleagues with whom she collaborates.
Dr. Lin is associate chief in the Division of Breast Oncology at the Susan F. Smith Center for Women’s Cancers, director of the Metastatic Breast Cancer Program and the Program for Patients with Breast Cancer Brain Metastases at the Dana-Farber Cancer Institute, and an associate professor of medicine at Harvard Medical School.
Read more in ASCO Connection.
